What is the initial empirical pharmacologic combination for suspected neonatal pneumonia?

• A. Cephalosporin and a penicillin
• B. Aminoglycoside and a cephalosporin
• C. Penicillin alone
• D. Penicillin and an aminoglycoside (correct)

Answer: (D)

Starting empirical therapy for suspected neonatal pneumonia is about covering the organisms most likely to cause infection in newborns. A penicillin provides reliable activity against Group B Streptococcus and Listeria, while an aminoglycoside adds strong Gram-negative coverage against organisms like E. coli and Klebsiella. The combination also leverages bactericidal synergy between a cell-wall–active antibiotic and an aminoglycoside, giving broad initial protection while culture results are pending. Monotherapy with penicillin would miss Gram-negative pathogens, and relying on other regimens may fail to cover Listeria or Group B Strep, which is why penicillin with an aminoglycoside is the preferred initial choice.